Search results for "sabi"

showing 10 items of 3020 documents

Autism spectrum disorders in children affected by Duchenne muscular dystrophy

2018

Background Duchenne muscular dystrophy (DMD) is the most frequent and severe form of the dystrophinopathies. The literature shows that about 30-40% of DMD subjects have intellectual disability. In males with Duchenne muscular dystrophy, neuropsychiatric disorders have also been observed: attention deficit disorder and hyperactivity, autism spectrum disorders, and obsessive-compulsive disorder. Duchenne muscular dystrophy is not just a muscle disorder, but also a disease that affects the brain. The aim of the present study was to describe a case series of children with Duchenne muscular dystrophy that have also the presence of autism spectrum disorders (ASDs). They have been assessed by mean…

0301 basic medicineDuchenne muscular dystrophyMalemedicine.medical_specialtyAutism Spectrum DisorderDuchenne muscular dystrophyMuscle disorderAudiologyAutism Diagnostic Observation Schedule03 medical and health sciences0302 clinical medicineIntellectual Disabilitymental disordersIntellectual disabilitymedicineHumansMuscular dystrophyChildbusiness.industryWechsler Adult Intelligence Scalemedicine.diseaseSettore MED/39 - Neuropsichiatria InfantileMuscular Dystrophy Duchenne030104 developmental biologyPediatrics Perinatology and Child HealthChildhood Autism Rating ScaleAutismAustism Spectrum Disorderbusiness030217 neurology & neurosurgeryHuman
researchProduct

Identification of novel mutations in L1CAM gene by a DHPLC-based assay

2016

X-linked hydrocephalus, MASA syndrome, X-linked complicated Spastic Paraplegia Type I, and X-linked partial agenesis of the corpus callosum are rare diseases mainly affecting male population and broadly referred as L1 syndrome, caused by mutations in the L1CAM gene. In the present study 36 boys and a male fetus whose clinical features were consistent with L1 syndrome were analyzed by dHPLC assay and direct sequencing of L1CAM gene. Sequence analysis of the 14 different aberrant dHPLC elution profiles demonstrated that six of them were associated with already reported polymorphisms, four with previously described causative variants while the remaining four represented novel L1CAM mutations. …

0301 basic medicineGeneticsCRASH syndromeHydrocephaluSequence analysisSpastic paraplegiaMASA syndromeL1-diseaseBiologyCorpus callosummedicine.diseaseBiochemistryHuman geneticsHydrocephalus03 medical and health sciences030104 developmental biologyIntellectual disabilityGeneticsmedicineAdducted thumbDifferential diagnosisL1 syndromeMolecular BiologyGenes & Genomics
researchProduct

Haploinsufficiency of ARFGEF1 is associated with developmental delay, intellectual disability, and epilepsy with variable expressivity

2021

PURPOSE: ADP ribosylation factor guanine nucleotide exchange factors (ARFGEFs) are a family of proteins implicated in cellular trafficking between the Golgi apparatus and the plasma membrane through vesicle formation. Among them is ARFGEF1/BIG1, a protein involved in axon elongation, neurite development, and polarization processes. ARFGEF1 has been previously suggested as a candidate gene for different types of epilepsies, although its implication in human disease has not been well characterized.METHODS: International data sharing, in silico predictions, and in vitro assays with minigene study, western blot analyses, and RNA sequencing.RESULTS: We identified 13 individuals with heterozygous…

0301 basic medicineGeneticsCandidate geneHeterozygoteEpilepsyADP ribosylation factorIn silicoHeterozygote advantageHaploinsufficiency030105 genetics & heredityBiologymedicine.disease03 medical and health sciencesEpilepsy030104 developmental biologyIntellectual DisabilitymedicineGuanine Nucleotide Exchange FactorsHumansGuanine nucleotide exchange factorHaploinsufficiencyGenetics (clinical)MinigeneGenetics in Medicine
researchProduct

STAG1 mutations cause a novel cohesinopathy characterised by unspecific syndromic intellectual disability

2017

Item does not contain fulltext BACKGROUND: Cohesinopathies are rare neurodevelopmental disorders arising from a dysfunction in the cohesin pathway, which enables chromosome segregation and regulates gene transcription. So far, eight genes from this pathway have been reported in human disease. STAG1 belongs to the STAG subunit of the core cohesin complex, along with five other subunits. This work aimed to identify the phenotype ascribed to STAG1 mutations. METHODS: Among patients referred for intellectual disability (ID) in genetics departments worldwide, array-comparative genomic hybridisation (CGH), gene panel, whole-exome sequencing or whole-genome sequencing were performed following the …

0301 basic medicineGeneticsMutationCohesin complexPoint mutationBiologymedicine.diseasemedicine.disease_causeBioinformaticsFrameshift mutation03 medical and health sciences030104 developmental biology0302 clinical medicineIntellectual disabilityGeneticsmedicineJournal ArticleMissense mutationGene030217 neurology & neurosurgeryGenetics (clinical)Exome sequencingRare cancers Radboud Institute for Health Sciences [Radboudumc 9]Journal of Medical Genetics
researchProduct

Diagnostic odyssey in severe neurodevelopmental disorders: toward clinical whole-exome sequencing as a first-line diagnostic test

2016

The current standard of care for diagnosis of severe intellectual disability (ID) and epileptic encephalopathy (EE) results in a diagnostic yield of ∼50%. Affected individuals nonetheless undergo multiple clinical evaluations and low-yield laboratory tests often referred to as a 'diagnostic odyssey'. This study was aimed at assessing the utility of clinical whole-exome sequencing (WES) in individuals with undiagnosed and severe forms of ID and EE, and the feasibility of its implementation in routine practice by a small regional genetic center. We performed WES in a cohort of 43 unrelated individuals with undiagnosed ID and/or EE. All individuals had undergone multiple clinical evaluations a…

0301 basic medicineGeneticsPediatricsmedicine.medical_specialtybusiness.industryEpileptic encephalopathyFirst lineSequencing dataData interpretationDiagnostic testmedicine.disease3. Good health03 medical and health sciences030104 developmental biologyCohortIntellectual disabilityGeneticsmedicinebusinessGenetics (clinical)Exome sequencingClinical Genetics
researchProduct

Autosomal recessive mutations inTHOC6cause intellectual disability: syndrome delineation requiring forward and reverse phenotyping

2016

THOC6 is a part of the THO complex, which is involved in coordinating mRNA processing with export. The THO complex interacts with additional components to form the larger TREX complex (transcription export complex). Previously, a homozygous missense mutation in THOC6 in the Hutterite population was reported in association with syndromic intellectual disability. Using exome sequencing, we identified three unrelated patients with bi-allelic mutations in THOC6 associated with intellectual disability and additional clinical features. Two of the patients were compound heterozygous for a stop and a missense mutation, and the third was homozygous for a missense mutation; the missense mutations wer…

0301 basic medicineGeneticseducation.field_of_studyMicrocephalybusiness.industryPopulationTranscription export complex030105 genetics & heredityCompound heterozygositymedicine.disease03 medical and health sciences030104 developmental biologyIntellectual disabilityGeneticsMedicineMissense mutationbusinesseducationExomeGenetics (clinical)Exome sequencingClinical Genetics
researchProduct

Genetic counselling difficulties and ethical implications of incidental findings from array-CGH: a 7-year national survey

2016

Microarray-based comparative genomic hybridization (aCGH) is commonly used in diagnosing patients with intellectual disability (ID) with or without congenital malformation. Because aCGH interrogates with the whole genome, there is a risk of being confronted with incidental findings (IF). In order to anticipate the ethical issues of IF with the generalization of new genome-wide analysis technologies, we questioned French clinicians and cytogeneticists about the situations they have faced regarding IF from aCGH. Sixty-five IF were reported. Forty corresponded to autosomal dominant diseases with incomplete penetrance, 7 to autosomal dominant diseases with complete penetrance, 14 to X-linked di…

0301 basic medicineGeneticsmedicine.medical_specialtyeducation.field_of_studyEthical issuesbusiness.industryGenetic counselingPopulationRetrospective cohort study030105 genetics & hereditymedicine.diseasePenetrance3. Good health03 medical and health sciencesGeneralization (learning)Family medicineIntellectual disabilityGeneticsMedicinebusinesseducationGenetics (clinical)Comparative genomic hybridizationClinical Genetics
researchProduct

Global, Regional, and National Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life-years for 3…

2017

Importance: Cancer is the second leading cause of death worldwide. Current estimates on the burden of cancer are needed for cancer control planning.Objective: To estimate mortality, incidence, years lived with disability (YLDs), years of life lost (YLLs), and disability-adjusted life-years (DALYs) for 32 cancers in 195 countries and territories from 1990 to 2015.Evidence Review: Cancer mortality was estimated using vital registration system data, cancer registry incidence data (transformed to mortality estimates using separately estimated mortality to incidence [MI] ratios), and verbal autopsy data. Cancer incidence was calculated by dividing mortality estimates through the modeled MI ratio…

0301 basic medicineGerontologyCancer ResearchPopulationArticle03 medical and health sciences0302 clinical medicineBreast cancerGlobal healthcancerMedicineDisability-adjusted life yeareducationDisease burdeneducation.field_of_studyestimate mortalityCancer preventioncancer preventionbusiness.industryMortality rate1. No povertymedicine.disease3. Good health030104 developmental biologyYears of potential life lostOncology030220 oncology & carcinogenesisbusinessearly diagnosisDemography
researchProduct

Specific approaches to patients affected by dementia and covid-19 in nursing homes: the role of the geriatrician

2021

The coronavirus disease 19 (COVID-19) is relevant in older people. Attention was given to the nursing homes in which frailer people are usually admitted. In this review, we discuss the approaches for daily problems found in nursing home as geriatricians and potentially new research directions. We start with the problem of the older people affected by dementia and Behavioral and Psychological Symptoms of Dementia for which also the execution of a simple diagnostic test (such as nasopharyngeal swab) could be problematic. Another important problem is the management of wandering patients for which the re-organization of the spaces and vaccination could be the solutions. The relationship with fa…

0301 basic medicineGerontologyGeriatricianAgingTelemedicinePalliative careInclusion (disability rights)Coronavirus disease 2019 (COVID-19)DiseaseBiochemistryArticle03 medical and health sciences0302 clinical medicinemedicineDementiaHumansMolecular BiologyAgedGeriatrician.business.industryNursing homeSARS-CoV-2COVID-19Geriatriciansmedicine.diseaseNursing Homes030104 developmental biologyNeurologyDementiaOlder peopleNursing homesbusiness030217 neurology & neurosurgeryBiotechnologyAgeing Research Reviews
researchProduct

How can dementia and disability be prevented in older adults: where are we today and where are we going?

2021

Abstract Ageing of the population, together with population growth, has brought along an ample increase in the number of older individuals living with dementia and disabilities. Dementia is the main cause of disability in old age, and promoting healthy brain ageing is considered as a key element in diminishing the burden of age‐related disabilities. The World Health Organization recently launched the first risk reduction guidelines for cognitive impairment and dementia. According to recent estimates, approximately 40% of dementia cases worldwide could be attributable to 12 modifiable risk factors: low education; midlife hypertension and obesity; diabetes, smoking, excessive alcohol use, phy…

0301 basic medicineGerontologyPhysical disabilityPopulationReviewsReview030204 cardiovascular system & hematologyehkäisevä lääketiedelaw.invention03 medical and health sciences0302 clinical medicineRandomized controlled trialpreventiontoimintakykylawRisk FactorsIntervention (counseling)Health careliikuntakykyInternal MedicineMedicineDementiaHumansCognitive DysfunctioneducationLife StyleDepression (differential diagnoses)cognitive impairmentAgedRandomized Controlled Trials as Topicmuistisairaudeteducation.field_of_studybusiness.industrymuscle physiologyliikuntarajoitteetCognitionriskitekijätmedicine.disease3. Good healthikääntyminen030104 developmental biologyageingDementiabusinessRisk Reduction BehaviorikääntyneetdementiaJournal of Internal Medicine
researchProduct